---
title: "EUDA Health Holdings Limited (EUDA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EUDA.US.md"
symbol: "EUDA.US"
name: "EUDA Health Holdings Limited"
industry: "Health Care Services"
datetime: "2026-05-21T15:56:33.384Z"
locales:
  - [en](https://longbridge.com/en/quote/EUDA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EUDA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EUDA.US.md)
---

# EUDA Health Holdings Limited (EUDA.US)

## Company Overview

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [eudahealth.com](https://eudahealth.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:19.000Z

**Overall: B (0.35)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 26 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 70.04% |  |
| Net Profit YoY | 81.94% |  |
| P/B Ratio | -10.64 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 45276732.00 |  |
| Revenue | 6820264.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 81.46% | A |
| Profit Margin | -40.65% | E |
| Gross Margin | 43.88% | B |
| Revenue YoY | 70.04% | A |
| Net Profit YoY | 81.94% | A |
| Total Assets YoY | 1.10% | C |
| Net Assets YoY | -65.92% | E |
| Cash Flow Margin | 87.51% | C |
| OCF YoY | 70.04% | A |
| Turnover | 4.00 | A |
| Gearing Ratio | 348.61% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - EUDA Health Holdings Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "70.04%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "81.94%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-10.64",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "45276732.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "6820264.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "81.46%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-40.65%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "43.88%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "70.04%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "81.94%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.10%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-65.92%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "87.51%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "70.04%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "4.00",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "348.61%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -16.33 | 53/87 | 385.95 | 262.28 | 102.48 |
| PB | -10.64 | 65/87 | - | - | - |
| PS (TTM) | 6.64 | 62/87 | 28.25 | 16.63 | 6.02 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-03-09T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 59.00 |
| Highest Target | 120.00 |
| Lowest Target | 120.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/EUDA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/EUDA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/EUDA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/EUDA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**